Trial Profile
Randomised Controlled Trial Investigation of Atomoxetine in Attention Deficit Hyperactivity Disorder.
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2016
Price :
$35
*
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms ACTION
- 30 Jun 2016 New trial record